Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (197)
  2. Journal Article (126)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (4)
  7. Correspondence (2)
  8. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (360)
  2. Department of Medicine (360)
  3. Hematologic Malignancies, Division of (360)
  4. Lymphoma (360)
  5. Population Sciences Research Program (235)
  6. Hematology-Oncology Fellows (164)

More Groups

People
  1. Steven Horwitz (234)
  2. Andrew Zelenetz (130)
  3. Paul Hamlin (119)
  4. Ariela Noy (118)
  5. Anita Kumar (106)
  6. Maria Palomba (103)

More People

Years
  1. 2025 (12)
  2. 2024 (37)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (150)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (22)
  4. Blood Advances (15)
  5. Journal of the American Academy of Dermatology (15)
  6. Leukemia and Lymphoma (15)

More Publications

Publishers
  1. American Society of Hematology (168)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (25)
  4. Elsevier Inc. (22)
  5. Taylor & Francis Group (16)
  6. Mosby Elsevier (15)

More Publishers

Results (360)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous T-cell lymphoma (CTCL), rare subtypes: Five case presentations and review of the literature
    Review

    Geller, S.; Myskowski, P. L.; Pulitzer, M.; Horwitz, S. M.; Moskowitz, A. J.
    Chinese Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma
    Journal Article

    Delea, T. E.; Sharma, A.; Grossman, A.; Eichten, C.; Fenton, K.; Josephson, N.; Richhariya, A.; Moskowitz, A. J.
    Journal of Medical Economics (2019)

    Fulltext@MSK | Save
  • Mycosis fungoides, psoriasis and anti-PD-1 - A new aspect of known associations
    Research Letter

    Geller, S.; Pulitzer, M.; Horwitz, S. M.; Moskowitz, A. J.; Myskowski, P. L.
    Journal Der Deutschen Dermatologischen Gesellschaft (2019)

    Fulltext@MSK | Save
  • Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
    Journal Article

    Mehta-Shah, N.; Ito, K.; Bantilan, K.; Moskowitz, A. J.; Sauter, C.; Horwitz, S. M.; Schöder, H.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: A retrospective analysis of 174 patients
    Journal Article

    Lebowitz, E.; Geller, S.; Flores, E.; Pulitzer, M.; Horwitz, S.; Moskowitz, A.; Kheterpal, M.; Myskowski, P. L.
    Journal of the European Academy of Dermatology and Venereology (2019)

    Fulltext@MSK | Save
  • Angioimmunoblastic T-cell lymphoma
    Journal Article

    Yabe, M.; Dogan, A.; Horwitz, S. M.; Moskowitz, A. J.
    Cancer Treatment and Research (2019)

    Fulltext@MSK | Save
  • Survival for relapsed/refractory Hodgkin lymphoma patients with recurrent or persistent disease following autologous hematopoietic stem cell transplantation treated in the modern era
    Meeting Abstract

    Rajeeve, S.; Shah, G. L.; Moskowitz, C. H.; Moskowitz, A. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Preliminary results from the phase 2 CheckMate 436 trial
    Meeting Abstract

    Moskowitz, A. J.; Santoro, A.; Gritti, G.; Brice, P.; Cunningham, D.; Barr, P.; Kline, J.; Kuruvilla, J.; Johnson, N. A.; Mehta-Shah, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Jacobsen, E. D.; Mehta-Shah, N.; Khodadoust, M. S.; Fisher, D. C.; Myskowski, P.; Wang, E. B. K.; Tawa, M.; Davey, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: Part 3 (concurrent dosing) results and updated progression-free survival results from parts 1 and 2 (staggered dosing)
    Meeting Abstract

    Advani, R. H.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Christian, B. A.; Ansell, S. M.; Moskowitz, C. H.; more...
    Blood (2018)

    Fulltext@MSK | Save